| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 21, 1159-1166, Copyright © 1975 by the American Association for Clinical Chemistry
1 Dr. Doumas is a member of the AACC Committee on Standards. His address is: Department of Pathology, The Medical College of Wisconsin, Milwaukee, Wis. 53233.
We have studied the standardization of total serum protein assay with the biuret reaction. Standard solutions were prepared from lyophilized preparations of human serum albumin and bovine serum albumin, with corrections made for volatile material and ash contents. These solutions and a solution of crystalline albumin standard were analyzed with a new stable biuret reagent, to establish absorptivity values (values for the absorbance of a 1 g/liter final reaction mixture). The mean values obtained were 0.302, 0.292, and 0.290 for human serum albumin, bovine serum albumin, and the crystalline albumin, respectively. We believe that the established absorptivity value will improve the accuracy of serum protein determinations. We studied the linearity of the relation between color produced and protein concentration, with use of the solutions described above and a serum pool. The color adheres to Beer's law up to the highest concentration tested: 3 g/liter for HSA and BSA, and 2.8 g/liter for serum in the final reaction mixture. The new biuret reagent has been stable for one year at room temperature. We recommend the use of bovine serum albumin as a primary standard for serum protein assays. It is inexpensive, easily available, and exhibits the best linearity in the biuret reaction.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  C. W. H. Woo, Y. L. Siow, G. N. Pierce, P. C. Choy, G. Y. Minuk, D. Mymin, and K. O Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1002 - E1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Nash, M. Olovsson, and U. J. Eriksson Placental Dysfunction in Suramin-Treated Rats: Impact of Maternal Diabetes and Effects of Antioxidative Treatment Reproductive Sciences, April 1, 2005; 12(3): 174 - 184. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Wei, C. Beeson, M. G. Masucci, and V. Levitsky A Partially Agonistic Peptide Acts as a Selective Inducer of Apoptosis in CD8+ CTLs J. Immunol., September 1, 1999; 163(5): 2601 - 2609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Brooks, R. A. Colbert, J. P. Mear, A. M. Leese, and A. B. Rickinson HLA-B27 Subtype Polymorphism and CTL Epitope Choice: Studies with EBV Peptides Link Immunogenicity with Stability of the B27:Peptide Complex J. Immunol., November 15, 1998; 161(10): 5252 - 5259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Levitsky, P.-O. de Campos-Lima, T. Frisan, and M. G. Masucci The Clonal Composition of a Peptide-Specific Oligoclonal CTL Repertoire Selected in Response to Persistent EBV Infection Is Stable Over Time J. Immunol., July 15, 1998; 161(2): 594 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. de Campos-Lima, R Gavioli, Q. Zhang, L. Wallace, R Dolcetti, M Rowe, A. Rickinson, and M. Masucci HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population Science, April 2, 1993; 260(5104): 98 - 100. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
